State-of-the-art Imaging Biomarkers

QMENTA has amassed the most advanced and widely used imaging biomarkers on its platform to enable experts to measure the efficacy of treatments under trial or research in a single environment.

Multiple Sclerosis

State-of-the-art biomarkers for lesion count, activity, load, diffusion, and volume

Alzheimer’s Disease

Advanced biomarkers for volumetry and connectivity

Parkinson’s Disease

Advanced biomarkers for volumetry and thickness

Brain Oncology

State-of-the-art biomarkers for contrast, perfusion, tumor volume, and Gadolinium

Neuropsychiatric Diseases

Advanced biomarkers for connectivity, volume, and thickness

Stroke

Cutting-edge mapping biomarker

Interested in our biomarkers?

Talk to our team to learn more.

Contact us